Smart Body sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
Survodutide is a synthetic research peptide supplied exclusively for laboratory research, peptide characterization, and scientific investigation. Produced using controlled peptide synthesis procedures, this lyophilized research material supports laboratory handling, storage stability, and analytical consistency.
Survodutide is an investigational once-weekly injectable dual receptor agonist targeting both the glucagon receptor (GCGR) and the glucagon-like peptide-1 (GLP-1) receptor. Developed jointly by Boehringer Ingelheim and Zealand Pharma, it is currently evaluated in Phase 3 clinical trials for obesity management and metabolic dysfunction-associated steatohepatitis (MASH)
Each production batch follows documented Quality Assurance and Quality Control procedures supporting batch consistency, traceability, and research documentation.
$200.00
100 in stock
Research Applications
Survodutide may be utilized in laboratory research involving:
Research applications may vary according to laboratory protocols and institutional requirements.
Storage & Handling
Quality Assurance
Survodutide is manufactured according to documented Quality Assurance and Quality Control procedures supporting HPLC analysis, purity verification, batch traceability, analytical consistency, and research documentation. Batch-specific Certificates of Analysis (COAs) are available where applicable.
